BMO Capital Starts Neos Therapeutics (NEOS) at Outperform
Tweet
Share
E-mailGet Alerts NEOS Hot Sheet
Price: $1.15 --0%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Join SI Premium – FREE
BMO Capital initiated coverage on Neos Therapeutics (NASDAQ: NEOS) with an Outperform rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Neos Therapeutics click here. For more ratings news on Neos Therapeutics click here.
Shares of Neos Therapeutics closed at $20.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosenblatt Starts CoreWeave (CRWV) at Buy
- Roth/MKM Starts Biodesix (BDSX) at Buy
- BTIG Starts Take-Two Interactive (TTWO) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
